SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-019868
Filing Date
2024-04-15
Accepted
2024-04-15 16:31:09
Documents
7
Period of Report
2024-06-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20023369x1_def14a.htm DEF 14A 689279
2 ny20023369x1_pvp01.jpg GRAPHIC 151146
3 ny20023369x1_pvp02.jpg GRAPHIC 164479
4 sig_adamgrossmanv2.jpg GRAPHIC 8489
5 sig_adamgrossmanv2x1.jpg GRAPHIC 9755
6 ny20023369x1-pc_1.jpg GRAPHIC 502991
7 ny20023369x1-pc_2.jpg GRAPHIC 434730
  Complete submission text file 0001140361-24-019868.txt   2440458
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36728 | Film No.: 24845041
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)